Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk

• Hannah Arem ,

  * E-mail: Hannah.arem@nih.gov

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Kai Yu,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Xiaoqin Xiong,

  Affiliation Information Management Systems, Inc., Calverton, Maryland, United States of America

  ⨯
• Kristin Moy,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Neal D. Freedman,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Susan T. Mayne,

  Affiliation Yale School of Public Health/Yale Cancer Center, New Haven, Connecticut, United States of America

  ⨯
• Demetrius Albanes,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Alan A. Arslan,

  Affiliation Departments of Population Health, Obstetrics and Gynecology (Obs/Gyn) and Environmental Medicine, New York University, New York, New York, United States of America

  ⨯
• Melissa Austin,

  Affiliation Department of Epidemiology, University of Washington, Seattle, Washington, United States of America

  ⨯
• William R. Bamlet,

  Affiliation Department of Epidemiology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Laura Beane-Freeman,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Paige Bracci,

  Affiliation Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Federico Canzian,

  Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Michelle Cotterchio,

  Affiliation Dalla Lana School of Public Health, University of Toronto; Prevention and Cancer Control, Cancer Care Ontario Toronto, Ontario, Canada

  ⨯
• Eric J. Duell,

  Affiliation Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain

  ⨯
• Steve Gallinger,

  Affiliation Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada

  ⨯
• Graham G. Giles,

  Affiliation Cancer Epidemiology Centre, Cancer Council Victoria and Centre for MEGA Epidemiology, School of Population Health, the University of Melbourne, Melbourne, Australia

  ⨯
• Michael Goggins,

  Affiliation Departments of Oncology, Pathology and Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Phyllis J. Goodman,

  Affiliation Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, Ohio, United States of America

  ⨯
• Patricia Hartge,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Manal Hassan,

  Affiliation Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Kathy Helzlsouer,

  Affiliation MD Mercy, Baltimore, Maryland, United States of America

  ⨯
• Brian Henderson,

  Affiliation Department of Preventative Medicine, School of Medicine, University of Southern California, Los Angeles, California, United States of America

  ⨯
• Elizabeth A. Holly,

  Affiliation Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Robert Hoover,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Eric J. Jacobs,

  Affiliation Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, United States of America

  ⨯
• Aruna Kamineni,

  Affiliation GroupHealth Research Institute, Seattle, Washington, United States of America

  ⨯
• Alison Klein,

  Affiliation MD Mercy, Baltimore, Maryland, United States of America

  ⨯
• Eric Klein,

  Affiliation Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, Ohio, United States of America

  ⨯
• Laurence N. Kolonel,

  Affiliation University of Hawaii Cancer Center, Manoa, Hawaii, United States of America

  ⨯
• Donghui Li,

  Affiliation Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Núria Malats,

  Affiliation Molecular Pathology Program, Spanish National Cancer Research Center, Madrid, Spain

  ⨯
• Satu Männistö,

  Affiliation National Institute for Health and Welfare, Department of Chronic Disease Prevention, Helsinki, Finland

  ⨯
• Marjorie L. McCullough,

  Affiliation Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, United States of America

  ⨯
• Sara H. Olson,

  Affiliation Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Irene Orlow,

  Affiliation Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Ulrike Peters,

  Affiliation Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, Ohio, United States of America

  ⨯
• Gloria M. Petersen,

  Affiliation Department of Epidemiology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Miquel Porta,

  Affiliation Hospital del Mar Institute of Medical Research (IMIM), and School of Medicine, Barcelona Spain

  ⨯
• Gianluca Severi,

  Affiliation Cancer Epidemiology Centre, Cancer Council Victoria and Centre for MEGA Epidemiology, School of Population Health, the University of Melbourne, Melbourne, Australia

  ⨯
• Xiao-Ou Shu,

  Affiliation Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, United States of America

  ⨯
• Kala Visvanathan,

  Affiliation MD Mercy, Baltimore, Maryland, United States of America

  ⨯
• Emily White,

  Affiliation Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, Ohio, United States of America

  ⨯
• Herbert Yu,

  Affiliation University of Hawaii Cancer Center, Manoa, Hawaii, United States of America

  ⨯
• Anne Zeleniuch-Jacquotte,

  Affiliation Departments of Population Health, Obstetrics and Gynecology (Obs/Gyn) and Environmental Medicine, New York University, New York, New York, United States of America

  ⨯
• Wei Zheng,

  Affiliation Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, United States of America

  ⨯
• Geoffrey S. Tobias,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Dennis Maeder,

  Affiliation Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

  ⨯
• Michelle Brotzman,

  Affiliation Westat, Rockville, Maryland, United States of America

  ⨯
• Harvey Risch,

  Affiliation Yale School of Public Health/Yale Cancer Center, New Haven, Connecticut, United States of America

  ⨯
• Joshua N. Sampson,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
•  [ ... ],
• Rachael Z. Stolzenberg-Solomon

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]